However, by considering patients' individual circumstances and taking the time to ensure that they use the appropriate inhaler and technique, everyone can benefit. Asthma and COPD have a huge ...

AstraZeneca's Breztri Aerosphere in India is made using a new type of gas (called a next-generation propellant) that does not contribute much to climate change.

Remote study conducted at Rutgers and elsewhere finds albuterol-budesonide mix cuts risk for mild cases and may let patients ...

AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced ...

That data can be used to check that a patient is using the correct technique to get a benefit from the inhaler, for example, and give patients and healthcare providers a view of how well they are ...

As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations ...

AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and biotech firm based in Cambridge, UK, reported positive results from its ...

Asthma is a chronic condition requiring ongoing care, even with no symptoms. Regular use of a preventer inhaler is key. Read more at straitstimes.com. Read more at straitstimes.com.

The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

A low-carbon version of a triple combination pMDI inhaler indicated for adults with moderate-to-severe COPD has been approved by the MHRA.